Rakesh Arya
Impact in
-
- Medicinal Plants and Neuroprotection
-
- MicroRNA in disease regulation
Papers in
-
- Medicinal Plants and Neuroprotection 3
- Phytochemicals and Medicinal Plants 3
-
- MicroRNA in disease regulation 4
- Co-authors
- Dipak DattaSanjeev MeenaAkhilesh SinghAnup K. SinghRanjan Kumar NandaJiaur R. GayenPriyanka PandeyOlivier Dormond
- Journals
- Frontiers in Immunology (2 papers)British Journal of Cancer (2 papers)International Journal of Molecular Sciences (2 papers)PLoS ONE (2 papers)Scientific Reports (1 paper)
- Partner nations
- IndiaUnited StatesSouth Korea
In The Last Decade
Rakesh Arya
35 papers receiving 720 citations
Peers
Comparison fields: 5 of 105
- Complementary and alternative medicine 74
- Cancer Research 113
- Molecular Biology 362
- Oncology 136
- Pharmacology 42
Countries citing papers authored by Rakesh Arya
This map shows the geographic impact of Rakesh Arya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rakesh Arya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rakesh Arya more than expected).
Fields of papers citing papers by Rakesh Arya
This network shows the impact of papers produced by Rakesh Arya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rakesh Arya. The network helps show where Rakesh Arya may publish in the future.
Co-authors
The 25 scholars most cited alongside Rakesh Arya, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 9 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 7 | |
| 4 | 2024 | 2 | |
| 5 | 2022 | 26 | |
| 6 | 2022 | 2 | |
| 7 | 2022 | 3 | |
| 8 | 2021 | 32 | |
| 9 | 2021 | 26 | |
| 10 | 2021 | 1 | |
| 11 | 2021 | 41 | |
| 12 | 2021 | 20 | |
| 13 | 2020 | 43 | |
| 14 | 2018 | 40 | |
| 15 | 2017 | 18 | |
| 16 | 2017 | 34 | |
| 17 | 2016 | 57 | |
| 18 | Piceatannol bolsteres fetal haemoglobin formation in K562 cells via p38 map kinase activation and ERK inactivation. | 2015 | 1 |
| 19 | 2014 | 19 | |
| 20 | 2008 | 2 |
About Rakesh Arya
Rakesh Arya is a scholar working on Complementary and alternative medicine, Cancer Research, Infectious Diseases, Molecular Biology and Otorhinolaryngology, having authored 36 papers that have together received 746 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (4 papers), Medicinal Plants and Neuroprotection (3 papers), Extracellular vesicles in disease (3 papers), Tuberculosis Research and Epidemiology (3 papers), Essential Oils and Antimicrobial Activity (3 papers), Phytochemicals and Medicinal Plants (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and COVID-19 Clinical Research Studies (2 papers). The work is most often cited by research in Complementary and alternative medicine (74 citations), Cancer Research (113 citations), Molecular Biology (362 citations), Oncology (136 citations) and Pharmacology (42 citations). Rakesh Arya has collaborated with scholars based in India, United States and South Korea. Frequent co-authors include Dipak Datta, Sanjeev Meena, Akhilesh Singh, Anup K. Singh, Ranjan Kumar Nanda, Jiaur R. Gayen, Priyanka Pandey, Olivier Dormond, Rama Kant Singh and Navneet Kumar Yadav. Their work appears in journals such as Frontiers in Immunology, British Journal of Cancer, International Journal of Molecular Sciences, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.